CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-21 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $0.47 | $1K | 3,264 |
| 2017-06-21 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −4,292 | 41,719 | ||
| 2017-06-21 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −3,000 | 17,875 | ||
| 2017-06-14 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $51.09 | $26K | 89,697 |
| 2017-06-14 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $51.09 | $26K | 89,737 |
| 2017-06-13 | Scadden David Director | Grant or award · Stock option (right to buy) | +8,000 | 8,000 | ||
| 2017-06-13 | MARAGANORE JOHN Director | Grant or award · Stock option (right to buy) | +8,000 | 8,000 | ||
| 2017-06-13 | Ho Maykin Director | Grant or award · Stock option (right to buy) | +8,000 | 8,000 | ||
| 2017-06-13 | Foster-Cheek Kaye I Director | Grant or award · Stock option (right to buy) | +9,000 | 9,000 | ||
| 2017-06-13 | CLARK IAN T Director | Grant or award · Stock option (right to buy) | +8,000 | 8,000 | ||
| 2017-06-13 | Clancy Paul J Director | Grant or award · Stock option (right to buy) | +9,000 | 9,000 | ||
| 2017-06-13 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $50.64 | $25K | 90,197 |
| 2017-06-13 | Cantley Lewis Clayton Jr. Director | Sale | −500 | $50.64 | $25K | 90,237 |
| 2017-06-13 | Cantley Lewis Clayton Jr. Director | Grant or award · Stock option (right to buy) | +8,500 | 8,500 | ||
| 2017-06-07 | Schenkein David P Chief Executive Officer | Option exercise | +1,900 | $0.30 | $575 | 1,900 |
| 2017-06-07 | Schenkein David P Chief Executive Officer | Sale | −1,900 | $50.02 | $95K | 0 |
| 2017-06-07 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −1,900 | 189,656 | ||
| 2017-06-06 | Schenkein David P Chief Executive Officer | Option exercise | +1,100 | $0.30 | $333 | 1,100 |
| 2017-06-06 | Schenkein David P Chief Executive Officer | Sale | −1,100 | $50.02 | $55K | 0 |
| 2017-06-06 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −1,100 | 191,556 |
Page 75 of 80 · 1,590 trades